About

Latest Updates

FDA Approves Deucravacitinib for Adults with Moderate-to-Severe Plaque Psoriasis

Secukinumab Receives Expanded Approvals in EU for Use in childhood Arthritic Conditions

FDA Approves Baricitinib As First and Only Systemic Medicine for Adults with Severe Alopecia Areata